| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.37 | 0.03 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.57 | 0.03 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.26 | 0.04 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.05 |